Prevalence of Constitutive and Inducible Clindamycin Resistance among Methicillin-Resistant Staphylococcus aureus Isolates in a Tertiary Care Hospital, Kashmir Valley

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 33

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JMMI-10-3_002

تاریخ نمایه سازی: 29 بهمن 1402

چکیده مقاله:

Introduction: The increased frequency of Methicillin-resistant Staphylococcus aureus infections has led to renewed interest in the macrolide-lincosamide streptogramin B (MLS) group of antibiotics. Resistance to these antibiotics may be constitutive or inducible. Isolates resistant to erythromycin may show false in vitro susceptibility to clindamycin, leading to therapeutic failures. This study investigated the utility of the D-Test for detecting inducible clindamycin resistance in methicillin-resistant S. aureus isolates and determining the prevalence of various phenotypes in our region. Methods: For detecting inducible clindamycin resistance, a D-test using erythromycin and clindamycin as per CLSI guidelines was performed, and four different phenotypes were interpreted as methicillin-sensitive (MS) phenotype (D-test negative), inducible MLSB (iMLSB) phenotype (D-test positive), constitutive MLSB phenotype and sensitive to both. Results: Of the ۹۸۷ isolates tested, ۴۰۰ (۴۰.۵۳%) were MRSA. The prevalence of iMLSB, cMLSB phenotype, MS phenotype and sensitive phenotype in MRSA isolates was ۴۲.۵%, ۱۰.۵%, ۲۸% and ۱۹%, respectively. The iMLSB and cMLSB phenotypes were higher in males (۲۴.۷۵%, ۶.۲۵%) than females (P-value = ۰.۱۳۷). The majority of MRSA isolates originated from pus (۸۳%). All S. aureus isolates showed ۱۰۰% sensitivity to vancomycin and linezolid.  Conclusion: This study emphasizes the prevalence of inducible clindamycin resistance in MRSA in our setup. Incorporating the D-test into the routine Kirby–Bauer disk diffusion method in clinical microbiology laboratories will help clinicians make judicious use of clindamycin, minimizing treatment failure.

نویسندگان

Shahida Akhter

Department of Microbiology, Government Medical College, Srinagar, India

Asifa Nazir

Department of Microbiology, Government Medical College, Srinagar, India

Ovais Karnain

Department of Microbiology, Government Medical College, Srinagar, India

Mariya Rouf

Department of Microbiology, Government Medical College, Srinagar, India

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. ...
  • Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect ...
  • Foster TJ, Höök M. Surface protein adhesins of Staphylococcus aureus. ...
  • DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community associated ...
  • National Nosocomial Infections Surveillance (NNIS) System Report, data summary from ...
  • David MZ, Daum RS. Community associated Methicillin resistant Staphylococcus aureus: ...
  • Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth ...
  • Patel AK, Patel KK, Patel KR, Shah S, Dileep P. ...
  • Gopalakrishnan R, Sureshkumar D. Changing trends in antimicrobial susceptibility and ...
  • D'Souza N, Rodrigues C, Mehta A. Molecular characterization of Methicillin-resistant ...
  • Ahmad S. Prevalence and susceptibility pattern of Methicillin Resistant Staphylococcus ...
  • Rajaduraipandi K, Mani KR, Panneerselvam KM, Bhaskar M, Manikandan P. ...
  • Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk ...
  • Dass BS, Nagarajan A, Krishnan P, Sivakumar G. clindamycin resistance ...
  • Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das BK, ...
  • Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I. ...
  • Azap O, Arslan H, Timurkaynak F, Yapar G, Oruc E, ...
  • Introduction to microbiology: Part II: Guidelines for collection, transport, processing, ...
  • Clinical and laboratory standard institute. Performance standards for antimicrobial susceptibility ...
  • Shetty J, Afroz Z. Prevalence of constitutive and inducible clindamycin ...
  • Singh T, Deshmukh AB, Chitnis V, Bajpai T. Inducible clindamycin ...
  • Reddy MC, Bindu HM, Soumendranath M, Kanta RC, Kapur I. ...
  • Patil NR, Mali US, Kulkarni SA, Ghorpade MV and Mane ...
  • Damke SS, Vishani S, Fule RP. Prevalence of inducible clindamycin ...
  • Tyagi S, Oberoi A. Inducible clindamycin resistance in staphylococcus aureus ...
  • Majhi S, Dash M, Mohapatra D, Mohapatra A, Chayani N. ...
  • Banik A, Khyriem AB, Gurung J, Lyngdoh VW. Inducible and ...
  • Mama M, Aklilu A, Misgna K, Tadesse M, Alemayehu E. ...
  • Jarajreh D, Aqel A, Alzoubi H, Al-Zereini W. Prevalence of ...
  • Sasirekha B, Usha MS, Amruta JA, Ankit S, Brinda N, ...
  • Appalaraju B, Jayakumar S. Inducible Clindamycin Resistance in Staphylococcus aureus ...
  • Mittal V, Kishore S, Siddique ME. Prevalence of inducible clindamycin ...
  • Pal N, Sharma B, Sharma R, Vyas L. Detection of ...
  • Shrestha B, Pokhrel BM, Mohapatra TM. Phenotypic characterization of nosocomial ...
  • Mokta KK, Verma S, Chauhan D, Ganju SA, Singh D, ...
  • Chudasama V, Solanki H, Vadsmiya M, Vegad MM. Prevalence of ...
  • Supriyarajvi, Gupta A, Tina G, Sharma BP. Detection of inducible ...
  • Koppada R, Meeniga S, Anke G. Inducible clindamycin resistance among ...
  • Sande (Tathe) SV. Phenotypic detection and incidence of inducible clindamycin ...
  • Lall M, Sahni AK. Prevalence of inducible clindamycin resistance in ...
  • Lyall KS, Veenu Gupta, and Deepinder Chhina. Inducible clindamycin resistance ...
  • Schreckenberger PC, Ilendo E, Ristow KL. Incidence of Constitutive and ...
  • Date K, Choudhary M, Thombare V. Inducible clindamycin resistance in ...
  • Santos Sanchez I, Mato R, de Lencastre H, Tomasz A; ...
  • Garoy EY, Gebreab YB, Achila OO, Tekeste DG, Kesete R, ...
  • Ghosh S, Banerjee M. Methicillin resistance & inducible clindamycin resistance ...
  • Motamedifar M, Ebrahim-Saraie HS, Mansury D. Patterns of Constitutive and ...
  • Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, ...
  • Nikbakht M, Rezaee MA, Hasani A, Nahaei MA, Sadeghi J, ...
  • Fomda BA, Ahmad PM, Zahoor D, Thokar MA, Nasir RA. ...
  • Anouk E Muller, JW Mouton, PM Oostvogel, PJ Rob, AV, ...
  • Martinez AG, Hammermann WA, Manson EO, Kaplan SL. Clindamycin treatment ...
  • Kasten MJ. Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc. ۱۹۹۹; ...
  • Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in staphylococci. ...
  • Johnson AP, Woodford N. Glycopeptide-resistant Staphylococcus aureus. J Atimicrob Chemother. ...
  • Eliopoulos GM. Quinupristin-dalfopristin and linezolid: Evidence and opinion. Cli Infect ...
  • نمایش کامل مراجع